| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6169461 | The Breast | 2015 | 5 Pages |
Abstract
In routine practice everolimus efficacy appears very close to the Bolero-2 results, although in more heavily pretreated patients. Everolimus based therapy appears feasible and side effects are similar to those previously reported. These data support the use of everolimus in daily practice.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
D. Chocteau-Bouju, C. Chakiba, L. Mignot, N. Madranges, J.-Y. Pierga, P. Beuzeboc, N. Quenel-Tueux, V. Dieras, H. Bonnefoi, M. Debled, P. Cottu,